Zhongke Guosheng (Hangzhou) Technology

Established in 2021 and based in Hangzhou, China, Zhongke Guosheng (Hangzhou) Technology is a biological technology company that focuses on design and development of biomass catalytic materials. It is headquartered in Hangzhou, with branch offices in Lishui and Taixing. The core team came from the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, with about 20 years experience in the field of biomass catalytic conversion and furan-based material design and development. In November 2023, it raised strategic investment.

In July 2024, the company closed a strategic investment from new investor Zhejiang Yuhang Industrial Transformation & Upgrading Investment.  In March 2025, Zhongke Guosheng secured CNY 200 million in Series A+ funding. The company's main business is research and development of bio-based compound HMF (5-hydroxymethylfurfural). Its self-developed products include 2,5-Furandicarboxylicacid (FDCA), 5-hydroxymethylfurfural (HMF), 2,5-tetrahydrofurandimethanol (THFDM) and polyethylene 2,5-furandicarboxylate (PEF).

The products can be used in the field of functional polyester, bio-based lubricants, feed or food additives, surfactants, and pharmaceutical intermediates. The company generates revenue by developing and providing furan bio-based materials. Following the newest round of fundraising, Zhongke Guosheng plans to construct a 10,000-ton production capacity in Taixing, Jiangsu, to accelerate capacity expansion and further reduce costs.